Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 33
Filter
2.
Nat Commun ; 14(1): 78, 2023 01 05.
Article in English | MEDLINE | ID: mdl-36604442

ABSTRACT

Carbapenemase-producing Enterobacterales (CPE) are spreading rapidly in hospital settings. Asymptomatic CPE gut colonisation may be associated with dysbiosis and gut-lung axis alterations, which could impact lung infection outcomes. In this study, in male C57BL/6JRj mice colonised by CPE, we characterise the resulting gut dysbiosis, and analyse the lung immune responses and outcomes of subsequent Pseudomonas aeruginosa lung infection. Asymptomatic gut colonisation by CPE leads to a specific gut dysbiosis and increases the severity of P. aeruginosa lung infection through lower numbers of alveolar macrophages and conventional dendritic cells. CPE-associated dysbiosis is characterised by a near disappearance of the Muribaculaceae family and lower levels of short-chain fatty acids. Faecal microbiota transplantation restores immune responses and outcomes of lung infection outcomes, demonstrating the involvement of CPE colonisation-induced gut dysbiosis in altering the immune gut-lung axis, possibly mediated by microbial metabolites such as short-chain fatty acids.


Subject(s)
Pseudomonas Infections , Pseudomonas aeruginosa , Animals , Mice , Male , Klebsiella pneumoniae , Dysbiosis , Mice, Inbred C57BL , Lung , Fatty Acids, Volatile
3.
Eur J Clin Microbiol Infect Dis ; 42(1): 61-66, 2023 Jan.
Article in English | MEDLINE | ID: mdl-36376766

ABSTRACT

We report in vivo development of cefiderocol (FDC) resistance among four sequential Pseudomonas aeruginosa clinical isolates ST244 recovered from a single patient, without exposure to FDC, which raises concern about the effectiveness of this novel drug. The first recovered P. aeruginosa isolate (P-01) was susceptible to FDC (2 µg/mL), albeit this MIC value was higher than that of a wild-type P. aeruginosa (0.12-0.25 µg/ml). The subsequent isolated strains (P-02, P-03, P-04) displayed increasing levels of FDC MICs (8, 16, and 64 µg/ml, respectively). Those isolates also showed variable and gradual increasing levels of resistance to most ß-lactams tested in this study. Surprisingly, no acquired ß-lactamase was identified in any of those isolates. Whole-genome sequence analysis suggested that this resistance was driven by multifactorial mechanisms including mutational changes in iron transporter proteins associated with FDC uptake, ampC gene overproduction, and mexAB-oprM overexpression. These findings highlight that a susceptibility testing to FDC must be performed prior to any prescription.


Subject(s)
Anti-Bacterial Agents , Pseudomonas Infections , Humans , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Anti-Bacterial Agents/metabolism , Pseudomonas aeruginosa , Cephalosporins/pharmacology , Cephalosporins/therapeutic use , beta-Lactamases/metabolism , Microbial Sensitivity Tests , Pseudomonas Infections/drug therapy , Pseudomonas Infections/microbiology , Cefiderocol
4.
Clin Infect Dis ; 76(5): 800-808, 2023 03 04.
Article in English | MEDLINE | ID: mdl-36285530

ABSTRACT

BACKGROUND: Primary immunodeficiencies (PIDs) in adults are mainly revealed by recurrent and/or severe bacterial infections. The objective of this study was to evaluate a systematic research strategy of PIDs in adults with unexplained bacterial infections, with a special focus on specific polysaccharide antibody deficiency (SPAD). METHODS: In this prospective multicenter study, inclusion criteria were recurrent benign upper and lower respiratory tract infections (RTIs) for at least two years (group 1), at least one upper or lower RTI requiring hospitalization (group 2), and/or at least one invasive infection documented with encapsulated bacteria (group 3). Main exclusion criteria were all local and general conditions that could explain infections. If no PID diagnosis was made, response to polysaccharide antigens was assessed using a pneumococcal polysaccharide vaccine. RESULTS: From March 2015 to March 2020, 118 patients were included (37 males, median age of 41 years): 73, 17, and 28 in groups 1, 2, and 3, respectively. Forty-seven PIDs were diagnosed, giving an estimated frequency of 39.8% (95% confidence interval [CI] [30.4, 48.8]). SPAD was the most frequent diagnosis by far (n = 37/47, 78.7%), and was made in 23, 5, and 9 patients from groups 1 to 3, respectively. All SPAD patients received conjugate vaccines and, according to their infectious history, were on surveillance or treated with preventive antibiotics (n = 6) and/or with immunoglobulins replacement therapy (n = 10), the latter being dramatically efficient in all cases. CONCLUSIONS: Considering its high prevalence among adults with unexplained recurrent and/or severe bacterial infections, SPAD should be screened in those patients. CLINICAL TRIALS REGISTRATION: NCT02972281.


Subject(s)
Bacterial Infections , Immunologic Deficiency Syndromes , Pneumococcal Infections , Primary Immunodeficiency Diseases , Male , Humans , Adult , Prospective Studies , Immunologic Deficiency Syndromes/complications , Immunologic Deficiency Syndromes/epidemiology , Immunologic Deficiency Syndromes/diagnosis , Polysaccharides , Bacterial Infections/epidemiology , Bacterial Infections/drug therapy , Primary Immunodeficiency Diseases/drug therapy , Bacteria , Pneumococcal Vaccines , Antibodies, Bacterial , Pneumococcal Infections/prevention & control
10.
Eur J Clin Microbiol Infect Dis ; 40(7): 1399-1404, 2021 Jul.
Article in English | MEDLINE | ID: mdl-33515094

ABSTRACT

A recently developed, automated blood culture system and medium improve the time-to-positivity (TTP) for bacteremia. However, there have thus far been no genus-level analyses using this novel system. We evaluated and compared the changes in blood culture TTP between two systems: BacT/Alert 3D with a blood culture medium containing activated charcoal versus the more recent BacT/Alert Virtuo with a blood culture medium containing polymeric beads. This before-and-after study included blood cultures collected between July 2010 and April 2014 (3D, activated charcoal) and between July 2015 and April 2018 (Virtuo, polymeric beads). A total of 554,732 blood cultures were included, 267,935 (48.30%) during the first period and 286,797 (51.70%) during the second period. Overall, 55,611 (10.02%) tested positive for at least one microorganism. The incubation of the blood culture medium in the Virtuo system was associated with reduced TTP for the most prevalent bacteria, those representing 91.72% (n=51,006) of all the positive blood cultures. The median TTP was reduced by 0.99 h for Staphylococcus, Enterococcus, Streptococcus, Pseudomonadales, and most of the genera within the order Enterobacterales (except the family Morganellaceae). However, strictly anaerobic bacteria belonging to the genus Bacteroides, representing 0.85% (n=474) of all positive blood cultures, were detected 4.53 h later using the Virtuo system. Virtuo was associated with a shorter TTP for most bacteria, but this improvement was heterogeneous to the genus level.


Subject(s)
Bacteremia/diagnosis , Blood Culture/methods , Automation , Bacteria/classification , Bacteria/isolation & purification , Bacteriological Techniques , Charcoal , Culture Media , Humans , Microspheres , Time Factors
11.
J Mol Diagn ; 23(2): 234-241, 2021 02.
Article in English | MEDLINE | ID: mdl-33259953

ABSTRACT

Bacterial vaginosis (BV) diagnosis in pregnancy is based on the Nugent score, which consists of semiquantitation of bacterial morphotypes. Limited data exist concerning molecular-based diagnosis in asymptomatic pregnant women. Using high-throughput quantitative PCR, 34 microorganisms were screened in asymptomatic pregnant women and compared with the Nugent score. Three-hundred and four vaginal samples had a Nugent score <7 (69.9%) and 131, a Nugent score ≥7 (30.1%), consistent with BV. More pregnant women with BV share Atopobiumvaginae, bacterial vaginosis associated bacteria-2, Gardnerella spp., Mobiluncus curtisii, Mo. mulieris, Mycoplasma hominis, Ureaplasma urealyticum, Prevotella bivia, Megasphaera 1, and Megasphaera 2 in their vaginal sample. Fewer pregnant women with BV share Lactobacillus crispatus, L. gasseri, L. jensenii, and Enterococcus faecalis in their vaginal sample (P < 0.001). Classification and regression tree analysis was performed to determine which combinations of detected bacteria optimally diagnose BV in this population. A set of only four bacteria of 34 microorganisms (A. vaginae, Gardnerella spp., L. crispatus, and P. bivia) was the best combination to identify BV in a cohort of asymptomatic pregnant women, with a sensitivity of 77.1%, and specificity of 97.0% compared with the Nugent score. The quantitative PCR in the present study responds to the limits of the Nugent score by implementing an easily reproducible quantitative assay to assess the absence of BV in pregnancy.


Subject(s)
Pregnant Women , Real-Time Polymerase Chain Reaction/methods , Vaginosis, Bacterial/diagnosis , Adult , Female , Humans , Regression Analysis , Vaginosis, Bacterial/microbiology
12.
Jpn J Infect Dis ; 74(4): 367-368, 2021 Jul 21.
Article in English | MEDLINE | ID: mdl-33250491

ABSTRACT

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently a major worldwide concern. Guidelines have been issued regarding precautions for healthcare workers caring for SARS-CoV-2-infected patients. Despite accurate observance of infection control measures, including contact precautions, we encountered an OXA-23-producing Acinetobacter baumannii outbreak in 5 intensive care units of 10 beds each in our tertiary care teaching hospital.


Subject(s)
Acinetobacter Infections/epidemiology , COVID-19/epidemiology , Acinetobacter baumannii/pathogenicity , Adult , Aged , Disease Outbreaks , Female , Health Personnel , Humans , Infection Control/methods , Male , Middle Aged , SARS-CoV-2/pathogenicity , Tertiary Care Centers
13.
Crit Care ; 24(1): 611, 2020 10 15.
Article in English | MEDLINE | ID: mdl-33076936

ABSTRACT

BACKGROUND: Gut dysbiosis due to the adverse effects of antibiotics affects outcomes of lung infection. Previous murine models relied on significant depletion of both gut and lung microbiota, rendering the analysis of immune gut-lung cross-talk difficult. Here, we study the effects of antibiotic-induced gut dysbiosis without lung dysbiosis on lung immunity and the consequences on acute P. aeruginosa lung infection. METHODS: C57BL6 mice received 7 days oral vancomycin-colistin, followed by normal regimen or fecal microbial transplant or Fms-related tyrosine kinase 3 ligand (Flt3-Ligand) over 2 days, and then intra-nasal P. aeruginosa strain PAO1. Gut and lung microbiota were studied by next-generation sequencing, and lung infection outcomes were studied at 24 h. Effects of vancomycin-colistin on underlying immunity and bone marrow progenitors were studied in uninfected mice by flow cytometry in the lung, spleen, and bone marrow. RESULTS: Vancomycin-colistin administration induces widespread cellular immunosuppression in both the lung and spleen, decreases circulating hematopoietic cytokine Flt3-Ligand, and depresses dendritic cell bone marrow progenitors leading to worsening of P. aeruginosa lung infection outcomes (bacterial loads, lung injury, and survival). Reversal of these effects by fecal microbial transplant shows that these alterations are related to gut dysbiosis. Recombinant Flt3-Ligand reverses the effects of antibiotics on subsequent lung infection. CONCLUSIONS: These results show that gut dysbiosis strongly impairs monocyte/dendritic progenitors and lung immunity, worsening outcomes of P. aeruginosa lung infection. Treatment with a fecal microbial transplant or immune stimulation by Flt3-Ligand both restore lung cellular responses to and outcomes of P. aeruginosa following antibiotic-induced gut dysbiosis.


Subject(s)
Anti-Bacterial Agents/adverse effects , Dysbiosis/complications , Immunosuppression Therapy/adverse effects , Pneumonia/etiology , Animals , Anti-Bacterial Agents/pharmacology , Disease Models, Animal , Dysbiosis/etiology , Dysbiosis/physiopathology , Immunosuppression Therapy/methods , Lung/microbiology , Lung/physiopathology , Mice, Inbred C57BL , Microbiota/drug effects , Pneumonia/physiopathology , Pseudomonas aeruginosa/drug effects , Vancomycin/adverse effects , Vancomycin/pharmacology
14.
Anaerobe ; 66: 102277, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32987144

ABSTRACT

Sneathia amnii is an opportunistic pathogen of the female reproductive tract that has been reported to cause infections during pregnancy and in the post-partum period. Infections outside the reproductive tract have rarely been described. We report the case of a spondylitis due to S. amnii in a 72-year old woman, successfully treated after seven weeks of antimicrobial therapy. Growth of this pathogen guided our diagnosis towards a gynecological pathology; we discovered an endometrium adenocarcinoma. This case emphasizes the need for adequate incubation of discal biopsies, using aerobic and anaerobic enrichment broth with prolonged incubation.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Fusobacteria/classification , Spondylitis/diagnosis , Spondylitis/microbiology , Adenocarcinoma , Aged , DNA, Bacterial , Endometrial Neoplasms , Female , Fusobacteria/drug effects , Fusobacteria/isolation & purification , Humans , RNA, Ribosomal, 16S , Spondylitis/drug therapy , Treatment Outcome
16.
Emerg Infect Dis ; 26(8): 1939-1941, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32298228
17.
Anaerobe ; 63: 102202, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32247000

ABSTRACT

Clostridium spp. are recovered from 25% of the blood culture positive with anaerobes. However, the clinical relevance of Clostridium bacteremia has been controverted in the literature, particularly for C. perfringens. We aimed to evaluate the clinical relevance of Clostridium bacteremia, either due to C. perfringens or other Clostridium species, and to identify the risk factors of mortality in these patients. A retrospective cohort study was conducted from January 2010 to April 2018. All the patients with at least one blood culture positive with any Clostridium species were included. Eighty-one patients with a least one blood culture positive with any Clostridium species were included. Seventy patients (86.4%) fulfilled the criteria for clinically relevant bacteremia. Bacteremia due to C. perfringens tended to be less clinically relevant than other Clostridium species but this was not statistically significant (76% vs 91.2%, P = 0.09). In case of clinically relevant bacteremia, the 30-day mortality rate was 31.4%. In multivariate analysis, adequate empiric antimicrobial therapy was significantly associated with survival (P = 0.03). In conclusion, bacteremia due to C. perfringens or other Clostridium species is usually clinically relevant. This finding was also supported by an improved survival at 30 days when adequate empiric antimicrobial therapy was administered.


Subject(s)
Bacteremia , Clostridium Infections , Clostridium/isolation & purification , Adult , Aged , Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Bacteremia/epidemiology , Clostridium/drug effects , Clostridium Infections/drug therapy , Clostridium Infections/mortality , Clostridium perfringens/drug effects , Clostridium perfringens/isolation & purification , Cohort Studies , Female , Humans , Hypothermia/microbiology , Male , Middle Aged , Mortality , Retrospective Studies , Risk Factors
18.
Anaerobe ; 59: 32-34, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31103530

ABSTRACT

Clostridium ventriculi (formerly Sarcina ventriculi) is a Gram-positive, obligate anaerobic coccus. Human infections due to this bacterium have rarely been reported, its involvement in the development of gastric ulcers and perforation has been suggested. We present a case of bacteremia due to C. ventriculi following acute colonic pseudo-obstruction.


Subject(s)
Bacteremia/diagnosis , Bacteremia/pathology , Clostridium Infections/diagnosis , Clostridium Infections/pathology , Clostridium/isolation & purification , Colonic Pseudo-Obstruction/complications , Aged , Bacteremia/microbiology , Clostridium Infections/microbiology , Humans , Male
19.
Article in English | MEDLINE | ID: mdl-30962336

ABSTRACT

While antibiotic use is a risk factor of carbapenemase-producing Enterobacteriaceae (CPE) acquisition, the importance of timing of antibiotic administration relative to CPE exposure remains unclear. In a murine model of gut colonization by New Delhi metallo-beta-lactamase-1 (NDM-1)-producing Klebsiella pneumoniae, a single injection of clindamycin within at most 1 week before or after CPE exposure induced colonization persisting up to 100 days. The timing of antibiotic administration relative to CPE exposure may be relevant to infection control and antimicrobial stewardship approaches.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Bacterial Proteins/metabolism , Enterobacteriaceae Infections/drug therapy , Enterobacteriaceae/drug effects , Gastrointestinal Microbiome/drug effects , beta-Lactamases/metabolism , Animals , Disease Models, Animal , Enterobacteriaceae/metabolism , Infection Control/methods , Klebsiella pneumoniae/drug effects , Klebsiella pneumoniae/metabolism , Mice , Microbial Sensitivity Tests/methods
20.
Article in English | MEDLINE | ID: mdl-30533763

ABSTRACT

Pseudomonas aeruginosa infections are challenging due to intrinsic and acquired resistance mechanisms. We report here the draft genome sequences of two multidrug-resistant strains-PAL0.1, isolated from the airways of an intensive care unit (ICU) patient with ventilator-associated pneumonia, and PAL1.1, isolated from blood cultures of an ICU patient with sepsis.

SELECTION OF CITATIONS
SEARCH DETAIL
...